With MITF's qualification as a lineage-specific oncogene14 in human melanoma, and its tight regulation downstream of MAPK signaling18, 21 (Supplementary Figure S1C), the heightened sensitivity of HMEL-B/M to MAPK signaling inhibitors is not unfounded. Here, MITF is linked to melanoma.